Flora Peyvandi to Surveys and Questionnaires
This is a "connection" page, showing publications Flora Peyvandi has written about Surveys and Questionnaires.
Connection Strength
0.008
-
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey. Haemophilia. 2021 Sep; 27(5):736-743.
Score: 0.008